Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Investments:
Fixed maturity available-for-sale securities, at fair value (amortized cost: 2019 – $94,295; 2018 – $92,429)	$ 105,200	$ 94,024
Trading securities	4,673	1,950
Equity securities	103	99
Mortgage loans on real estate	16,339	13,260
Policy loans	2,477	2,509
Derivative investments	1,911	1,107
Other investments	2,994	2,267
Total investments	133,697	115,216
Cash and invested cash	2,563	2,345
Deferred acquisition costs and value of business acquired	7,694	10,264
Premiums and fees receivable	465	570
Accrued investment income	1,148	1,119
Reinsurance recoverables	17,144	17,748
Funds withheld reinsurance assets	536	557
Goodwill	1,778	1,782
Other assets	16,170	15,713
Separate account assets	153,566	132,833
Total assets	334,761	298,147
Liabilities
Future contract benefits	36,420	34,648
Other contract holder funds	98,018	91,233
Short-term debt	300
Long-term debt	6,067	5,839
Reinsurance related embedded derivatives	327	3
Funds withheld reinsurance liabilities	1,810	1,740
Payables for collateral on investments	5,082	4,805
Other liabilities	13,482	12,696
Separate account liabilities	153,566	132,833
Total liabilities	315,072	283,797
Contingencies and Commitments (See Note 14)
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized
Common stock – 800,000,000 shares authorized; 196,668,532 and 205,862,760 shares issued and outstanding as of December 31, 2019, and December 31, 2018, respectively	5,162	5,392
Retained earnings	8,854	8,551
Accumulated other comprehensive income (loss)	5,673	407
Total stockholders' equity	19,689	14,350
Total liabilities and stockholders' equity	$ 334,761	$ 298,147